TuHURA Biosciences, Inc.
HURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $76,330 | $4,194 | $319 | $710 |
| - Cash | $12,657 | $3,665 | $14,253 | $5,546 |
| + Debt | $203 | $2,345 | $138 | $644 |
| Enterprise Value | $63,876 | $2,874 | -$13,795 | -$4,192 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$117 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$17,427 | -$29,121 | -$9,561 | -$6,007 |
| % Margin | – | – | – | – |
| Net Income | -$21,682 | -$29,317 | -$9,368 | -$7,017 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.214 | -11.291 | -324.485 | -903.035 |
| % Growth | 89.3% | 96.5% | 64.1% | – |
| Operating Cash Flow | -$14,728 | -$11,951 | -$7,508 | -$6,563 |
| Capital Expenditures | -$58 | -$79 | -$232 | -$3 |
| Free Cash Flow | -$14,786 | -$12,030 | -$7,545 | -$6,567 |